{"id":751,"date":"2020-07-07T09:23:00","date_gmt":"2020-07-07T09:23:00","guid":{"rendered":"http:\/\/model1.caplinpoint.net\/?p=751"},"modified":"2021-07-30T09:22:03","modified_gmt":"2021-07-30T09:22:03","slug":"brief-caplin-point-laboratories-unit-signs-pact-with-xellia-pharmaceuticals","status":"publish","type":"post","link":"http:\/\/model1.caplinpoint.net\/index.php\/2020\/07\/07\/brief-caplin-point-laboratories-unit-signs-pact-with-xellia-pharmaceuticals\/","title":{"rendered":"BRIEF-Caplin Point Laboratories Unit Signs Pact With Xellia Pharmaceuticals"},"content":{"rendered":"\n<p>CAPLIN STERILES SIGNS PACT WITH XELLIA<br>PHARMACEUTICALS<\/p>\n\n\n\n<p>CAPLIN STERILES TO LICENSE 5 INJECTABLE ANDAS TO<br>XELLIA<\/p>\n\n\n\n<p>APPROVAL FOR 4 PRODUCTS EXPECTED WITHIN NEXT 12-18 MONTHS Source text for Eikon.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.reuters.com\/article\/brief-caplin-point-laboratories-ltd-capl\/brief-caplin-point-laboratories-ltd-caplin-steriles-gets-usfda-approval-for-verapamil-hydrochloride-injection-usp-idUKFWN2BI1O1\">https:\/\/www.reuters.com\/article\/brief-caplin-point-laboratories-ltd-capl\/brief-caplin-point-laboratories-ltd-caplin-steriles-gets-usfda-approval-for-verapamil-hydrochloride-injection-usp-idUKFWN2BI1O1<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CAPLIN STERILES SIGNS PACT WITH XELLIAPHARMACEUTICALS CAPLIN STERILES TO LICENSE 5 INJECTABLE ANDAS TOXELLIA APPROVAL FOR 4 PRODUCTS EXPECTED WITHIN NEXT 12-18 MONTHS Source text for Eikon. https:\/\/www.reuters.com\/article\/brief-caplin-point-laboratories-ltd-capl\/brief-caplin-point-laboratories-ltd-caplin-steriles-gets-usfda-approval-for-verapamil-hydrochloride-injection-usp-idUKFWN2BI1O1<\/p>\n","protected":false},"author":1,"featured_media":1229,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[],"_links":{"self":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/751"}],"collection":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/comments?post=751"}],"version-history":[{"count":2,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/751\/revisions"}],"predecessor-version":[{"id":779,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/751\/revisions\/779"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/media\/1229"}],"wp:attachment":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/media?parent=751"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/categories?post=751"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/tags?post=751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}